Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Capital Employed (2016 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Return on Capital Employed for 12 consecutive years, with 0.37% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 12.0% year-over-year to 0.37%, compared with a TTM value of 0.37% through Dec 2025, down 12.0%, and an annual FY2025 reading of 0.34%, up 1.0% over the prior year.
  • Return on Capital Employed was 0.37% for Q4 2025 at Agios Pharmaceuticals, down from 0.35% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.17% in Q2 2021 and bottomed at 0.54% in Q2 2024.
  • Average Return on Capital Employed over 5 years is 0.33%, with a median of 0.33% recorded in 2022.
  • The sharpest move saw Return on Capital Employed soared 31bps in 2021, then fell -19bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.26% in 2021, then dropped by -28bps to 0.34% in 2022, then dropped by -28bps to 0.43% in 2023, then soared by 40bps to 0.26% in 2024, then tumbled by -45bps to 0.37% in 2025.
  • Business Quant data shows Return on Capital Employed for AGIO at 0.37% in Q4 2025, 0.35% in Q3 2025, and 0.32% in Q2 2025.